Ghent University Academic Bibliography

Your filters: cql: author="Keymeulen, Bart" or (type any "bookEditor issueEditor" and editor="Keymeulen, Bart")

Add to list
One-year real-world benefits of Tandem Control-IQ technology on glucose management and person-reported outcomes in adults with type 1 diabetes : a prospective observational cohort study

Jolien De Meulemeester, Bart Keymeulen, Christophe De Block, Liesbeth Van Huffel, Youri Taes, Dominique Ballaux, Katrien Spincemaille, Bruno Lapauw (UGent) , Gerd Vanhaverbeke, Ine Lowyck, et al.

(2025) DIABETOLOGIA. 68(5). p.948-960
Add to list
Repeated OGTT versus continuous glucose monitoring for predicting development of stage 3 type 1 diabetes : a longitudinal analysis

Aster K. Desouter, Bart Keymeulen, Ursule Van de Velde, Annelien Van Dalem, Bruno Lapauw (UGent) , Christophe De Block, Pieter Gillard, Nicole Seret, Eric V. Balti, Elena R. Van Vooren, et al.

(2025) DIABETES CARE. 48(4). p.528-536
Add to list
Cost–utility analysis of Dexcom G6 real-time continuous glucose monitoring versus FreeStyle Libre 1 intermittently scanned continuous glucose monitoring in adults with type 1 diabetes in Belgium

Margaretha M. Visser, Astrid Van Muylder, Sara Charleer, John J. Isitt, Stéphane Roze, Christophe De Block, Toon Maes, Gerd Vanhaverbeke, Frank Nobels, Bart Keymeulen, et al.

(2024) DIABETOLOGIA. 67(4). p.650-662
Add to list
- Conference Paper
- C3
Real-world improvements in glycemic control and patient-reported outcomes one year after initiation of tandem control-IQ in people with type 1 diabetes

Jolien De Meulemeester, Sara Charleer, Margaretha M. Visser, Christophe De Block, Liesbeth Van Huffel, Youri Taes, Dominique Ballaux, Katrien Spincemaille, Bruno Lapauw (UGent) , Gerd Vanhaverbeke, et al.

(2024) DIABETES TECHNOLOGY & THERAPEUTICS. In Diabetes Technology & Therapeutics 26(Supplement 2). p.A77-A77
Add to list
- Journal Article
- A1
- open access
The MicroRNA landscape of acute beta cell destruction in type 1 diabetic recipients of intraportal islet grafts

Geert Martens (UGent) , Geert Stangé, Lorenzo Piemonti, Jasper Anckaert (UGent) , Zhidong Ling, Daniel G. Pipeleers, Frans K. Gorus, Pieter Mestdagh (UGent) , Dieter De Smet, Jo Vandesompele (UGent) , et al.

(2021) CELLS. 10(7).
Add to list
Use of culture to reach metabolically adequate beta-cell dose by combining donor islet cell isolates for transplantation in type 1 diabetes patients

DaHae Lee, Pieter Gillard, Robert Hilbrands, Zhidong Ling, Ursule Van de Velde, Daniel Jacobs-Tulleneers-Thevissen, Geert Maleux, Bruno Lapauw (UGent) , Laurent Crenier, Christophe De Block, et al.

(2020) TRANSPLANTATION. 104(10). p.E295-E302
Add to list
- Conference Paper
- C3
- open access
Chronic complications versus glycaemic variability, time in range and HbA(1c) in people with type 1 diabetes : sub study of the RESCUE-trial

A. El Malahi, M. Van Elsen, S. Charleer, F. De Ridder, K. Ledeganck, Bart Keymeulen, L. Crenier, R. Radermecker, Bruno Lapauw (UGent) , C. Vercammen, et al.

(2020) DIABETOLOGIA. In Diabetologia 63(Supplement 1). p.S19-S19
Add to list
- Conference Paper
- C3
- open access
Quality of life versus glycaemic variability and time in range in people with type 1 diabetes : sub study of the RESCUE-trial

P. Gillard, A. El Malahi, M. Van Elsen, S. Charleer, F. De Ridder, K. Ledeganck, Bart Keymeulen (UGent) , L. Crenier, R. Radermecker, Bruno Lapauw (UGent) , et al.

(2020) DIABETOLOGIA. In Diabetologia 63(Supplement 1). p.S371-S372
Add to list
Zusto : a new sweetening agent with low glycemic index

Joeri Jan Pen, Galina Khorosheva, Ursule Van de Velde, Corinne Debroye, André Huyghebaert (UGent) , Raoul Rottiers (UGent) and Bart Keymeulen

(2018) CLINICAL NUTRITION ESPEN. 23. p.103-106
Add to list
Effect of continuous glucose monitoring on glycemic control, acute admissions, and quality of life : a real-world study

Sara Charleer, Chantal Mathieu, Frank Nobels, Christophe De Block, Regis P Radermecker, Michel P Hermans, Youri Taes, Chris Vercammen, Guy T'Sjoen (UGent) , Laurent Crenier, et al.

(2018) JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM. 103(3). p.1224-1232

Academic Bibliography

One-year real-world benefits of Tandem Control-IQ technology on glucose management and person-reported outcomes in adults with type 1 diabetes : a prospective observational cohort study

Repeated OGTT versus continuous glucose monitoring for predicting development of stage 3 type 1 diabetes : a longitudinal analysis

Cost–utility analysis of Dexcom G6 real-time continuous glucose monitoring versus FreeStyle Libre 1 intermittently scanned continuous glucose monitoring in adults with type 1 diabetes in Belgium

Real-world improvements in glycemic control and patient-reported outcomes one year after initiation of tandem control-IQ in people with type 1 diabetes

The MicroRNA landscape of acute beta cell destruction in type 1 diabetic recipients of intraportal islet grafts

Use of culture to reach metabolically adequate beta-cell dose by combining donor islet cell isolates for transplantation in type 1 diabetes patients

Chronic complications versus glycaemic variability, time in range and HbA(1c) in people with type 1 diabetes : sub study of the RESCUE-trial

Quality of life versus glycaemic variability and time in range in people with type 1 diabetes : sub study of the RESCUE-trial

Zusto : a new sweetening agent with low glycemic index

Effect of continuous glucose monitoring on glycemic control, acute admissions, and quality of life : a real-world study

Contents

Support

Contact